139 related articles for article (PubMed ID: 32235863)
21. Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay.
Chen CZ; Southall N; Xiao J; Marugan JJ; Ferrer M; Hu X; Jones RE; Feng S; Agoulnik IU; Zheng W; Agoulnik AI
J Biomol Screen; 2013 Jul; 18(6):670-7. PubMed ID: 23212924
[TBL] [Abstract][Full Text] [Related]
22. Relaxin/insulin-like family peptide receptor 4 (Rxfp4) expressing hypothalamic neurons modulate food intake and preference in mice.
Lewis JE; Woodward OR; Nuzzaci D; Smith CA; Adriaenssens AE; Billing L; Brighton C; Phillips BU; Tadross JA; Kinston SJ; Ciabatti E; Göttgens B; Tripodi M; Hornigold D; Baker D; Gribble FM; Reimann F
Mol Metab; 2022 Dec; 66():101604. PubMed ID: 36184065
[TBL] [Abstract][Full Text] [Related]
23. Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4).
Chen Y; Zhou Q; Wang J; Xu Y; Wang Y; Yan J; Wang Y; Zhu Q; Zhao F; Li C; Chen CW; Cai X; Bathgate RAD; Shen C; Eric Xu H; Yang D; Liu H; Wang MW
Nat Commun; 2023 Jan; 14(1):492. PubMed ID: 36717591
[TBL] [Abstract][Full Text] [Related]
24. Evidence that RXFP4 is located in enterochromaffin cells and can regulate production and release of serotonin.
Fernando SJA; Wang Q; Hay DL; Bathgate RAD; Shepherd PR; Lee KL
Biosci Rep; 2023 Apr; 43(4):. PubMed ID: 36947541
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5).
Akhter Hossain M; Bathgate RA; Kong CK; Shabanpoor F; Zhang S; Haugaard-Jönsson LM; Rosengren KJ; Tregear GW; Wade JD
Chembiochem; 2008 Jul; 9(11):1816-22. PubMed ID: 18576448
[TBL] [Abstract][Full Text] [Related]
26. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
27. Structure and function relationship of murine insulin-like peptide 5 (INSL5): free C-terminus is essential for RXFP4 receptor binding and activation.
Belgi A; Hossain MA; Shabanpoor F; Chan L; Zhang S; Bathgate RA; Tregear GW; Wade JD
Biochemistry; 2011 Oct; 50(39):8352-61. PubMed ID: 21866895
[TBL] [Abstract][Full Text] [Related]
28. The insulinotrophic effect of insulin-like peptide 5 in vitro and in vivo.
Luo X; Li T; Zhu Y; Dai Y; Zhao J; Guo ZY; Wang MW
Biochem J; 2015 Mar; 466(3):467-73. PubMed ID: 25514935
[TBL] [Abstract][Full Text] [Related]
29. Single chain peptide agonists of relaxin receptors.
Praveen P; Kocan M; Valkovic A; Bathgate R; Hossain MA
Mol Cell Endocrinol; 2019 May; 487():34-39. PubMed ID: 30641102
[TBL] [Abstract][Full Text] [Related]
30. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY
J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726
[TBL] [Abstract][Full Text] [Related]
31. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY
Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931
[TBL] [Abstract][Full Text] [Related]
32. Immune System Effects of Insulin-Like Peptide 5 in a Mouse Model.
Vahkal B; Yegorov S; Onyilagha C; Donner J; Reddick D; Shrivastav A; Uzonna J; Good SV
Front Endocrinol (Lausanne); 2020; 11():610672. PubMed ID: 33519716
[TBL] [Abstract][Full Text] [Related]
33. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
[TBL] [Abstract][Full Text] [Related]
34. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
[TBL] [Abstract][Full Text] [Related]
35. Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile.
Wilson KJ; Xiao J; Chen CZ; Huang Z; Agoulnik IU; Ferrer M; Southall N; Hu X; Zheng W; Xu X; Wang A; Myhr C; Barnaeva E; George ER; Agoulnik AI; Marugan JJ
Eur J Med Chem; 2018 Aug; 156():79-92. PubMed ID: 30006176
[TBL] [Abstract][Full Text] [Related]
36. A Novel Antagonist Peptide Reveals a Physiological Role of Insulin-Like Peptide 5 in Control of Colorectal Function.
Pustovit RV; Zhang X; Liew JJ; Praveen P; Liu M; Koo A; Oparija-Rogenmozere L; Ou Q; Kocan M; Nie S; Bathgate RA; Furness JB; Hossain MA
ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1665-1674. PubMed ID: 34661082
[TBL] [Abstract][Full Text] [Related]
37. Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.
Xiao J; Huang Z; Chen CZ; Agoulnik IU; Southall N; Hu X; Jones RE; Ferrer M; Zheng W; Agoulnik AI; Marugan JJ
Nat Commun; 2013; 4():1953. PubMed ID: 23764525
[TBL] [Abstract][Full Text] [Related]
38. Receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
[TBL] [Abstract][Full Text] [Related]
39. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation.
Hu MJ; Shao XX; Li HZ; Nie WH; Wang JH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2018 Aug; 50(8):1111-1119. PubMed ID: 29770870
[TBL] [Abstract][Full Text] [Related]
40. Engineering of a Novel Simplified Human Insulin-Like Peptide 5 Agonist.
Patil NA; Hughes RA; Rosengren KJ; Kocan M; Ang SY; Tailhades J; Separovic F; Summers RJ; Grosse J; Wade JD; Bathgate RA; Hossain MA
J Med Chem; 2016 Mar; 59(5):2118-25. PubMed ID: 26824523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
